US FDA Approves KLOXXADO® (naloxone HCl) Nasal Spray 8 mg to Treat Opioid Overdose
On April 30, 2021, the US Food and Drug Administration approved of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg, a new opioid overdose reversal medication.
Naloxone,...
Posts about:
On April 30, 2021, the US Food and Drug Administration approved of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg, a new opioid overdose reversal medication.
Naloxone,...